Purchase Order 36C26225P0058

Award Date 10/3/24
Potential Completion Date 10/31/24
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus Transducers, a cancer therapy product utilizing Tumor Treating Fields (TTFields) technology. The contract does not have a set-aside designation and is part of Novocure's 5-year, $28.85 million Federal...
This is a $49,748.73 firm fixed-price purchase order contract awarded by the Veterans Health Administration (VHA) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of tumor treating fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's efforts to expand veteran access to...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $33,165.82 contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This order is issued under Novocure's existing 5-year, $28.85 million Federal...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $21,000.00, is for the delivery of Novocure's Optune Plus Transducers, which are part of the company's Optune system for delivering Tumor Treating Fields (TTFields) therapy to treat solid tumor cancers, including glioblastoma and mesothelioma. This contract is not...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations. Novocure acts...
This is a firm-fixed-price purchase order awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $16,582.91 and a performance period ending on October 9, 2024. The award is for Optune Plus Transducer, part of Novocure's proprietary Optune system that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and other...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit organization specializing in cancer therapy with Tumor Treating Fields (TTFields). The contract is to provide Novocure's Optune PLUS transducers, a medical device that delivers therapeutic alternating electric fields to disrupt solid tumor cancer cell division. The contract has a completion date of September 27, 2024 and a...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company, to provide Optune Plus Transducers. The order has a potential value of $49,748.73 and a completion date of May 31, 2024. This order is part of a larger 5-year Federal Supply Schedule (FSS) contract with the VA VHA valued at up to $28.85 million, which allows the VA to efficiently procure Novocure's Optune tumor...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) therapy devices, transducer arrays, and related equipment rentals and support services for the treatment of solid tumor cancers, including glioblastoma, for veterans at VA medical centers and clinics. The contract has a potential value of $103,914.55 and a...
This $99,497.46 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure's proprietary Optune system delivers alternating electric...

This is a purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune Plus Transducers, an FDA-approved cancer therapy device that uses Tumor Treating Fields (TTFields) technology. The contract has a firm fixed price of $49,748.73 and a period of performance through October 31, 2024. The contract does not utilize any set-aside designations. This award is part of a larger $28.85 million Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) between Novocure and the VA VHA, which provides a streamlined procurement vehicle for the VA to acquire Novocure's Optune TTFields therapy products and services. The FSS contract was awarded in November 2022 and runs through October 31, 2027, enabling the VA to continue offering this innovative cancer treatment option to veteran patients diagnosed with glioblastoma and other solid tumor cancers.

Generated 10/4/24, 9:04 AM